Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 138 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1371 8.8 months Metastatic, castration-resistant prostate cancer 4 Biologic therapy
Duke University Medical Center United States 12/2013
Treatment Details: Patients: This phase 2 study involved 11 previously treated, castration-resistant, metastatic prostate cancer patients. The median patient age was 61 years. Treatment: Patients were tr
 
1372 8.8 months NSCLC 4 Chemotherapy
British Columbia Cancer Agency Canada 12/2013
Treatment Details: Patients: This phase 2 study involved 37 non-small-cell lung cancer patients. The median patient age was 63 years and 23 were male. Treatment: Patients were treated with the chemothera
 
1373 8.8 months Platinum-resistant ovarian cancer 5 Chemotherapy
Imperial College London United Kingdom 1/2014
Treatment Details: Patients: This phase 3 study involved platinum-resistant ovarian cancer patients who were separated into two treatment groups. Group A consisted of 70 women with a median age of 57.5 years
 
1374 8.8 months Metastatic Bladder Cancer 4 Chemotherapy
Kitasato University School of Medicine Japan 4/2015
Treatment Details: Patients: This study involved 10 metastatic urothelial carcinoma patients who had received two prior chemotherapy regimens. The median patient age was 67 years and 8 were male. Treatmen
 
1375 8.7 months Metastatic Melanoma 5 Biologic therapy
Chemotherapy
Memorial Sloan-Kettering Cancer Center United States 8/2014
Treatment Details: Patients: This phase 2 study involved metastatic melanoma patients who were divided into two separate treatment groups. Group A consisted of 52 patients with a median age 63.0 years and 71
 
1376 8.7 months Stage IV melanoma 4 Chemotherapy
Immunotherapy
Istituto Oncologico Veneto Italy 6/2011
Treatment Details: Patients: This phase III study involved stage IV melanoma patients who were divided into two separate treatment groups. Group A consisted of 75 patients with a median age of 54.5 years and
 
1377 8.7 months Peripheral T-cell lymphoma 5 Biologic therapy
Chemotherapy
Hormone
Kyungpook National University Hospital Korea 6/2007
Treatment Details: Patients: This phase 2 study involved 20 peripheral T-cell lymphoma patients. The median patient age was 50.5 years and 14 were male. Treatment: Patients were treated with the chemothe
 
1378 8.7 months Malignant Pleural Mesothelioma 1 Radiation
Sir Charles Gairdner Hospital Australia 7/2004
Treatment Details: Patients: This study involved 43 patients with malignant pleural mesothelioma. Only a subset of patients were administered the radiotherapy treatment. Treatment: The treatment consisted
 
1379 8.7 months Advanced NSCLC 5 Chemotherapy
The Sarah Cannon Cancer Center and Tennessee Oncology United States 9/2002
Treatment Details: Patients: This Phase II study involved a total of 267 patients with advanced (Stage IIIB and IV) non-small-cell lung carcinoma. Patients were divided into 4 groups: Group A contained 71 pat
 
1380 8.7 months Hormone-refractory prostate cancer 4 Chemotherapy
H. Lee Moffitt Cancer Center & Research Institute United States 8/2007
Treatment Details: Patients: This phase II trial involved 39 men with hormone-refractory, metastatic prostate cancer. All had a prior cytotoxic therapy and their disease progressed. The median age was 73 ye
 
Page 138 of 187  | Previous Page  | Next Page